Second Genome is at the cutting edge of microbiome science, translating breakthrough research into medicines and other novel products that help humanity.
Our scientists and staff are true pioneers in this dynamic field. We are advancing a pipeline of novel therapies for serious diseases, while also making new breakthroughs in multiple fields of research using our one-of-a kind discovery platform. With our impact felt across industries — from healthcare and nutrition to agriculture — we are recognized as global leaders in translating rapidly emerging science into products that help humanity.
Second Genome’s culture of excellence also makes us the expert-partner of choice for exciting microbiome research projects with leading corporations, academic institutions and government.
While we are driven by science, it is our people who are at the core of our success. We are committed to hiring top talent, rewarding our employees and creating an atmosphere that fosters creativity and continued growth.
Location: United States, California, South San Francisco
Employees: 11-50
Total raised: $56M
Founded date: 2009
Investors 4
| Date | Name | Website |
| - | Digitalis ... | digitalisv... |
| - | Lifeforce ... | lifeforcec... |
| - | Lightstone... | lightstone... |
| - | SR One | srone.com |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 13.07.2016 | Series B | $8.4M | - |
| 21.04.2016 | Series B | $42.6M | - |
| 10.08.2011 | Series A | $5M | - |
Mentions in press and media 17
| Date | Title | Description | Source |
| 17.04.2019 | Salesforce CEO Marc Benioff invests in $25M round for Naveen... | (Viome Photo) Viome, a wellness startup from entrepreneur Naveen Jain, has raised $25 million in fu... | geekwire.c... |
| 17.04.2019 | As researchers pursue links between bacteria and human healt... | In 2009, the National Institutes of Health launched a five-year, $150 million project to stimulate r... | techcrunch... |
| 04.01.2019 | Up to $818 million deal between J&J and Locus Bioscience... | The up to $818 million deal between Locus Biosciences and Janssen Pharmaceuticals (a division of Joh... | techcrunch... |
| 30.01.2018 | 5 projects using AI to combat global inequality | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI an... | venturebea... |
| 30.11.2016 | Axial Biotherapeutics raises $19.15M to target gut-brain axi... | This builds on an array of preclinical research that has shown a link between gut bacteria and neuro... | medcitynew... |
| 13.07.2016 | Biopharmaceutical Company Second Genome Raises $8.4M in Seri... | Second Genome, a South San Francisco, California-based biopharmaceutical company, raised $8.4m in Se... | finsmes.co... |
| 21.04.2016 | Second Genome Closes $42.6M Series B Funding | Second Genome, Inc., a South San Francisco, CA-based biopharmaceutical company developing novel medi... | finsmes.co... |
| 09.06.2014 | Seres Health adds Mayo Clinic in $10M series B to advance mi... | The level of interest in the microbiome has been compared to genomics. It’s a an area of growing inv... | medcitynew... |
| 07.05.2014 | Pfizer joins the microbiome movement, enlisting Second Genom... | In an effort to better understand the relationship between the microbiome, obesity and metabolic dis... | medcitynew... |
| 26.12.2013 | 5 biotech startups braving the new world of microbiome thera... | Drug discovery firm Second Genome, founded in 2010, raised an $11.5 million Series A round this year... | medcitynew... |
Show more